KRS
MRNA icon

Kentucky Retirement Systems’s Moderna MRNA Stock Holding History

Kentucky Retirement Systems’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-22,269
Closed -$657K – 617
2025
Q4 		$657K Hold
22,269
– – 0.02% 482
2025
Q3 		$575K Buy
22,269
+1,563
+8% +$43.6K 0.02% 490
2025
Q2 		$571K Sell
20,706
-1,358
-6% -$35.8K 0.02% 482
2025
Q1 		$626K Sell
22,064
-1,181
-5% -$41.9K 0.02% 484
2024
Q4 		$967K Sell
23,245
-321
-1% -$15.3K 0.03% 423
2024
Q3 		$1.57M Sell
23,566
-1,559
-6% -$143K 0.05% 336
2024
Q2 		$2.98M Sell
25,125
-67
-0.3% -$8.48K 0.09% 210
2024
Q1 		$2.68M Sell
25,192
-1,349
-5% -$136K 0.08% 244
2023
Q4 		$2.64M Buy
26,541
+852
+3% +$71.7K 0.08% 250
2023
Q3 		$2.65M Sell
25,689
-670
-3% -$74.7K 0.09% 225
2023
Q2 		$3.2M Buy
26,359
+236
+0.9% +$31.5K 0.11% 193
2023
Q1 		$4.01M Sell
26,123
-328
-1% -$54.1K 0.15% 140
2022
Q4 		$4.75M Buy
26,451
+116
+0.4% +$19K 0.19% 119
2022
Q3 		$3.11M Buy
26,335
+651
+3% +$98.8K 0.13% 160
2022
Q2 		$3.67M Buy
25,684
+3,200
+14% +$457K 0.16% 141
2022
Q1 		$3.87M Buy
22,484
+1,193
+6% +$201K 0.16% 132
2021
Q4 		$5.41M Buy
21,291
+393
+2% +$115K 0.22% 95
2021
Q3 		$8.04M Buy
+20,898
New +$7.71M 0.38% 58

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Kentucky Retirement Systems's MRNA Position: Q1 2026 in Review

Kentucky Retirement Systems sold out of Moderna (MRNA) in Q1 2026, closing a stake of 22,269 shares — an estimated $657K sold.

Kentucky Retirement Systems first reported a position in MRNA in Q3 2021 and held it in 18 quarters. The position peaked at $8.04M in Q3 2021. 722 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Kentucky Retirement Systems reported no remaining Moderna position as of Q1 2026 after selling out during the quarter.
  • Kentucky Retirement Systems sold 22,269 Moderna shares in Q1 2026, an estimated $657K.
  • Kentucky Retirement Systems first reported a position in Moderna in Q3 2021 and held it in 18 quarters.
  • Kentucky Retirement Systems's Moderna position peaked at $8.04M in Q3 2021.
  • 722 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Kentucky Retirement Systems's 13F filing for Q1 2026, filed 19 May 2026.